Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 28.27% is in line with its 5-year average of 26.67%, near the high end of its 5-year range (23.34%–30.17%).
As of the fiscal period ended Friday, July 31, 2026. 5.21% above its 12-month average of 26.87%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
28.27%
DEBT TO ASSETS RATIO AVG TTM
26.87%
DEBT TO ASSETS RATIO AVG 3Y
26.66%
DEBT TO ASSETS RATIO AVG 5Y
26.67%
DEBT TO ASSETS RATIO AVG 10Y
25.69%
DEBT TO ASSETS RATIO AVG 15Y
24.79%
DEBT TO ASSETS RATIO AVG 20Y
25.15%
CURRENT VS TTM AVG
+5.21%
CURRENT VS 3Y AVG
+6.05%
CURRENT VS 5Y AVG
+6.00%
CURRENT VS 10Y AVG
+10.05%
CURRENT VS 15Y AVG
+14.04%
CURRENT VS 20Y AVG
+12.44%
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+9997.78%
vs the sector median at left
Agilent Technologies, Inc.
Market Cap
$42.60B
Debt to Assets Ratio
28.27%
TTM Avg
26.87%
3Y Avg
26.66%
5Y Avg
26.67%
Market Cap
$42.35B
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.23B
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.61B
Debt to Assets Ratio
0.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.90B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.76B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | $42.60B | 28.27% | 26.87% | 26.66% | 26.67% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.35B | 0.42% | N/A | N/A | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $42.23B | 0.32% | N/A | N/A | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $44.07B | 0.54% | N/A | N/A | N/A |
| Humana Inc. (HUM)vs › | $48.22B | 0.25% | N/A | N/A | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $35.61B | 0.23% | N/A | N/A | N/A |
| Alcon Inc. (ALC)vs › | $34.38B | 0.17% | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX)vs › | $50.90B | 0.33% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $51.76B | 0.05% | N/A | N/A | N/A |
| DexCom, Inc. (DXCM)vs › | $33.17B | 0.22% | N/A | N/A | N/A |
Debt/Assets
28.3%
Debt/Equity
0.54
Current Ratio
2.05
Interest Coverage
13.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 28.27% |
| 2026-04-30 | 25.68% |
| 2026-01-31 | 26.18% |
| 2025-10-31 | 26.35% |
| 2025-07-31 | 27.88% |
| 2025-04-30 | 28.75% |
| 2025-01-31 | 28.23% |
| 2024-10-31 | 30.17% |
| 2024-07-31 | 26.66% |
| 2024-04-30 | 23.54% |
| 2024-01-31 | 23.34% |
| 2023-10-31 | 25.41% |
| 2023-07-31 | 26.13% |
| 2023-04-30 | 25.32% |
| 2023-01-31 | 27.21% |
| 2022-10-31 | 26.29% |
| 2022-07-31 | 27.78% |
| 2022-04-30 | 27.79% |
| 2022-01-31 | 26.44% |
| 2021-10-31 | 25.49% |
| 2021-07-31 | 27.24% |
| 2021-04-30 | 28.20% |
| 2021-01-31 | 25.83% |
| 2020-10-31 | 24.50% |
| 2020-07-31 | 24.33% |
| 2020-04-30 | 26.31% |
| 2020-01-31 | 25.91% |
| 2019-10-31 | 25.47% |
| 2019-07-31 | 20.85% |
| 2019-04-30 | 19.93% |
| 2019-01-31 | 20.08% |
| 2018-10-31 | 21.06% |
| 2018-07-31 | 21.55% |
| 2018-04-30 | 24.08% |
| 2018-01-31 | 24.66% |
| 2017-10-31 | 23.87% |
| 2017-07-31 | 25.19% |
| 2017-04-30 | 25.49% |
| 2017-01-31 | 25.30% |
| 2016-10-31 | 24.43% |
| 2016-07-31 | 24.40% |
| 2016-04-30 | 24.73% |
| 2016-01-31 | 23.73% |
| 2015-10-31 | 22.13% |
| 2015-07-31 | 22.82% |
| 2015-04-30 | 22.34% |
| 2015-01-31 | 22.05% |
| 2014-10-31 | 15.38% |
| 2014-07-31 | 21.35% |
| 2014-04-30 | 24.42% |
| 2014-01-31 | 25.33% |
| 2013-10-31 | 25.26% |
| 2013-07-31 | 26.28% |
| 2013-04-30 | 22.25% |
| 2013-01-31 | 22.16% |
| 2012-10-31 | 22.42% |
| 2012-07-31 | 22.69% |
| 2012-04-30 | 23.13% |
| 2012-01-31 | 23.97% |
| 2011-10-31 | 24.12% |
| 2011-07-31 | 24.77% |
| 2011-04-30 | 24.79% |
| 2011-01-31 | 26.59% |
| 2010-10-31 | 38.07% |
| 2010-07-31 | 40.42% |
| 2010-04-30 | 37.26% |
| 2010-01-31 | 38.43% |
| 2009-10-31 | 38.16% |
| 2009-07-31 | 32.76% |
| 2009-04-30 | 32.76% |
| 2009-01-31 | 30.77% |
| 2008-10-31 | 30.33% |
| 2008-07-31 | 30.70% |
| 2008-04-30 | 30.94% |
| 2008-01-31 | 28.50% |
| 2007-10-31 | 27.63% |
| 2007-07-31 | 21.36% |
| 2007-04-30 | 20.60% |
| 2007-01-31 | 20.85% |
| 2006-10-31 | 20.36% |
| 2006-07-31 | 19.41% |
| 2006-04-30 | 18.62% |
| 2006-01-31 | 18.69% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 15.64% |
| 2005-04-30 | 15.82% |
| 2005-01-31 | 16.08% |
| 2004-10-31 | 16.10% |
| 2004-07-31 | 17.06% |
| 2004-04-30 | 17.23% |
| 2004-01-31 | 18.01% |
| 2003-10-31 | 18.26% |
| 2003-07-31 | 19.20% |
| 2003-04-30 | 15.10% |
| 2003-01-31 | 14.80% |
| 2002-10-31 | 14.02% |
